4.6 Review

Long non-coding RNAs regulate the hallmarks of cancer in HPV-induced malignancies

Journal

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 161, Issue -, Pages -

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2021.103310

Keywords

HPV; LncRNAs; HPV-induced cancers; Cancer hallmarks; Biomarkers

Funding

  1. Portuguese League Against Cancer-Regional Nucleus of the North (Liga Portuguesa Contra o Cancro-Nucleo Regional do Norte)
  2. Research Center of the Portuguese Oncology Institute of Porto [PI86-CI-IPOP-66-2017]
  3. FCT-Fundacao para a Ciencia e a Tecnologia [SFRH/BD/135871/2018]
  4. Laboratory for Process Engineering, Environment, Biotechnology, and Energy-LEPABE - FCT/MCTES (PIDDAC) [UIDB/00511/2020]
  5. Fundação para a Ciência e a Tecnologia [SFRH/BD/135871/2018] Funding Source: FCT

Ask authors/readers for more resources

High-risk human papillomavirus (HPV) is a common sexually transmitted agent responsible for 5% of human cancers. Long non-coding RNAs (lncRNAs) play a crucial role in regulating biological processes and have potential as biomarkers or therapy targets in HPV-induced malignancies. Further research is needed to understand the mechanisms of lncRNAs in HPV-induced cancers.
High-risk human papillomavirus (HPV) is the most frequent sexually transmitted agent worldwide and is responsible for approximately 5% of human cancers. Identifying novel biomarkers and therapeutic targets for these malignancies requires a deeper understanding of the mechanisms involved in the progression of HPVinduced cancers. Long non-coding RNAs (lncRNAs) are crucial in the regulation of biological processes. Importantly, these molecules are key players in the progression of multiple malignancies and are able to regulate the development of the different hallmarks of cancer. This review highlights the action of lncRNAs in the regulation of cellular processes leading to the typical hallmarks of cancer. The regulation of lncRNAs by HPV oncogenes, their targets and also their mechanisms of action are also discussed, in the context of HPV-induced malignancies. Overall, accumulating data indicates that lncRNAs may have a significant potential to become useful tools for clinical practice as disease biomarkers or therapy targets.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available